Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2004-10-12
pubmed:abstractText
This study is a long-term follow-up analysis evaluating clinical outcome of patients with mantle-cell lymphoma treated by the sequential CHOP and DHAP chemotherapy followed by autografting. The median overall survival of 81 months (95% CI, 66-not reached) and the median event free survival of 51 months (95% CI, 43-not reached) confirm the improvement in outcome obtained by such protocol.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1592-8721
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1275-6
pubmed:meshHeading
pubmed-meshheading:15477221-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15477221-Cisplatin, pubmed-meshheading:15477221-Combined Modality Therapy, pubmed-meshheading:15477221-Cyclophosphamide, pubmed-meshheading:15477221-Cytarabine, pubmed-meshheading:15477221-Dexamethasone, pubmed-meshheading:15477221-Disease Progression, pubmed-meshheading:15477221-Disease-Free Survival, pubmed-meshheading:15477221-Doxorubicin, pubmed-meshheading:15477221-Etoposide, pubmed-meshheading:15477221-Follow-Up Studies, pubmed-meshheading:15477221-Humans, pubmed-meshheading:15477221-Life Tables, pubmed-meshheading:15477221-Lymphoma, Mantle-Cell, pubmed-meshheading:15477221-Peripheral Blood Stem Cell Transplantation, pubmed-meshheading:15477221-Prednisone, pubmed-meshheading:15477221-Prognosis, pubmed-meshheading:15477221-Prospective Studies, pubmed-meshheading:15477221-Salvage Therapy, pubmed-meshheading:15477221-Survival Analysis, pubmed-meshheading:15477221-Transplantation, Autologous, pubmed-meshheading:15477221-Vincristine, pubmed-meshheading:15477221-Whole-Body Irradiation
pubmed:year
2004
pubmed:articleTitle
Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.
pubmed:publicationType
Letter, Clinical Trial